Global Radiopharmaceuticals & Contrast Media Market (2026-2032) | Strategic Insights, Restraints, Analysis, Drivers, Investment Trends, Value, Industry, Share, Demand, Segmentation, Pricing Analysis, Competition, Strategy, Segments, Trends, Size, Revenue, Opportunities, Consumer Insights, Supply, Outlook, Companies, Growth, Challenges, Forecast, Competitive

Market Forecast by Regions and Countries (North America, Europe, LATAM, Middle East, Asia and Africa), By Type of Imaging Modality (Tc-99, Tl-201, Ga-67, I-123, Other SPECTs), By PET (F-18, Rb-82, Other PETs), By Diagnostic SPECT Application (Cardiology, Neurology, Thyroid, Other SPECT Applications), By PET Applications (Oncology, Cardology, Neurology, Other PET Applications), By Therapeutic Application (Thyroid, Lymphoma, Endocrine Tumors, Other Therapeutic Applications), By Contrast Media Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), By Procedure (X-ray/Computed Tomography (CT), Magnetic Resnance Imaging (MRI), Ultrasound), By Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders, Neurological Disorders, Other Indications) And Competitive Landscape
Product Code: ETC13228379 Publication Date: Apr 2025 Updated Date: Sep 2026 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Deep No. of Pages: 190 No. of Figures: 80 No. of Tables: 40
  • Table of Content
  • Related Topics
  • Request Customization

Global Radiopharmaceuticals & Contrast Media Market Highlights

Market Size (2025) USD 13.5 Billion
Forecast Size (2032) USD 22.2 Billion
CAGR 7.13%
Base Year 2025
Forecast Period 2026-2032
Largest Region North America
Fastest Growing Region Asia-Pacific
Largest Segment Tc-99
Fastest Growing Segment Other SPECTs
Leading Companies GE Healthcare, Siemens Healthineers, Cardinal Health, Bayer AG, Advanced Accelerator Applications

Global Radiopharmaceuticals & Contrast Media Market Size & Growth Rate (2026-2032)

Global Radiopharmaceuticals & Contrast Media Market Size & Growth Rate (2026-2032)

The Global Radiopharmaceuticals & Contrast Media Market was estimated at USD 13.5 Billion in 2025 and is projected to reach USD 22.2 Billion by 2032, growing at a CAGR of 7.13% from 2026 to 2032.

Global Radiopharmaceuticals & Contrast Media Market Synopsis

The Global Radiopharmaceuticals & Contrast Media Market is undergoing transformative changes, marked by enhancements in diagnostic capabilities and therapeutic applications. As healthcare systems increasingly prioritize early detection and precision treatment, radiopharmaceuticals are gaining prominence in oncology and cardiology, where their utilization significantly improves patient outcomes.

Simultaneously, technological innovations such as advanced imaging systems and hybrid modalities are redefining industry dynamics. These advancements, combined with heightened regulatory support, are crucial drivers, enabling broader applications and fostering collaboration among key stakeholders, from manufacturers to healthcare providers.

Global Radiopharmaceuticals & Contrast Media Market Year-wise Growth Rate and Key Drivers

This graph illustrates the annual growth rates of the Global Radiopharmaceuticals & Contrast Media Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

Global Radiopharmaceuticals & Contrast Media Market Year-wise Growth Rate and Key Drivers

The table below presents the year‑wise growth rates along with the key drivers influencing the market

Year Growth Rate (%) Major Drivers
2022 6 As supply chain dynamics stabilize, radiopharmaceuticals gain accessibility for clinical trials.
2023 8.08 A skilled workforce enhances radiopharmaceutical development and patient outcomes data collection.
2024 4.88 Regulatory agencies like the FDA streamline approval processes for contrast media applications.
2025 10.23 Advancements in drug delivery systems significantly improve radiopharmaceutical efficacy and adoption.
2026 7.17 A shift toward integrated diagnostic imaging technologies broadens user adoption of contrast media.
2027 9.22 Manufacturers adapt to a competitive landscape by enhancing radiopharmaceutical safety profiles.
2028 4.44 Healthcare providers increasingly prioritize sustainable practices in radiopharmaceutical production and usage.
2029 6.93 PET scans utilizing advanced radiopharmaceuticals expand rapidly across emerging Asian markets.
2030 11.64 Surge in M&A activity catalyzes investment in next-generation contrast media technologies.
2031 6.39 Increased costs of raw materials pressure radiopharmaceutical manufacturers to optimize production.
2032 5.92 Changing patient preferences drive demand for personalized contrast media in diagnostic imaging.

Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.

Global Radiopharmaceuticals & Contrast Media Market Key Takeaways

Below are some of the specific key takeaways from the market, including:

  • North America accounts for approximately 45% of the market share in 2025, influenced by advanced healthcare infrastructure and high diagnostic demand.
  • The Other SPECTs segment is projected to grow at a CAGR of 8.2% from 2026 to 2032, driven by increasing applications in neurology.
  • GE Healthcare announced a partnership with a leading cancer research institute, strengthening its foothold in innovative diagnostics.
  • By 2032, the Asia-Pacific region is expected to exhibit the highest CAGR of 8.0%, reflecting expanding healthcare accessibility and technological investments.

Evaluation of Restraints in Global Radiopharmaceuticals & Contrast Media Market

One significant restraint impacting the Global Radiopharmaceuticals & Contrast Media Market is the rigorous regulatory framework governing the approval processes for new products. For instance, the average time for regulatory approval can exceed 5 years, complicating market entry for new entrants and delaying innovations. These prolonged approval times can deter investment from smaller companies, limiting the overall growth potential of the market. Additionally, the high costs associated with the development of radiopharmaceuticals can reach upwards of $500 million, making it challenging for organizations to justify expenditures without guaranteed returns.

Global Radiopharmaceuticals & Contrast Media Market Trends

Currently, several trends are influencing the Global Radiopharmaceuticals & Contrast Media Market landscape. One of the most significant shifts is the increasing use of positron emission tomography (PET) in oncology. Companies like Siemens Healthineers have introduced innovations like the Biograph Vision, which offers enhanced sensitivity and resolution, allowing for more accurate tumor localization. Furthermore, the integration of artificial intelligence in medical imaging is accelerating interpretation times and improving diagnostic accuracy, positioning AI as an indispensable tool moving forward.

Additionally, the rise in personalized medicine is evident; tailored radiopharmaceuticals are being developed to better target specific patient profiles. A notable example includes the FDA’s approval of novel radioactive tracers that cater specifically to personalized cancer treatment regimens. These developments underscore a core pivot towards precision diagnostics, aligning with broader healthcare industry trends.

Global Radiopharmaceuticals & Contrast Media Market Opportunities

Emerging revenue opportunities in the Global Radiopharmaceuticals & Contrast Media Market are closely tied to the rise of molecular imaging technologies. For instance, increased R&D investments directed towards non-invasive imaging techniques could revolutionize diagnostics. A projected funding boost of $300 million from national health agencies aims to advance this facet. Companies like Cardinal Health are actively pursuing collaborations to leverage these opportunities, enriching their product offerings and establishing a stronger market presence.

Furthermore, advancements in the field of radiotherapy using radiopharmaceuticals reflect additional growth potential. As clinicians increasingly adopt targeted alpha therapies, the market can expect heightened demand for tailored diagnostics that optimize patient outcomes. The global market can capitalize on these avenues to drive future innovations and revenue streams.

Global Radiopharmaceuticals & Contrast Media Market by Type of Imaging Modality

In the Global Radiopharmaceuticals & Contrast Media Market, Tc-99 occupies the leading position, commanding approximately 40% share in 2025. With its wide applications in both diagnostic and therapeutic domains, Tc-99 remains favored by healthcare professionals. Conversely, Other SPECTs is the fastest-growing segment, anticipated to achieve a CAGR of 8.5% from 2026 to 2032, largely due to increasing utilization in advanced neurology assessments and therapeutic applications.

Global Radiopharmaceuticals & Contrast Media Market by PET

Within the PET segment, F-18 holds the largest market share, estimated to be around 35% in 2025, driven by its high efficacy in cancer diagnosis and monitoring. Rb-82, however, is the fastest-growing value, projected to grow at a CAGR of 9.0% from 2026 to 2032 due to its advantages in cardiac imaging, especially in dynamic myocardial perfusion assessments.

Global Radiopharmaceuticals & Contrast Media Market by Diagnostic SPECT Application

In terms of diagnostic SPECT applications, Cardiology is the largest segment, accounting for approximately 50% share in 2025. This dominance is linked to the high utilization of SPECT imaging in cardiac assessments and management. Neurology, however, exhibits the fastest growth rate, expected to register a CAGR of 9.5% from 2026 to 2032, spurred by heightened focus on neurodegenerative disorders and improved imaging modalities tailored for brain studies.

Global Radiopharmaceuticals & Contrast Media Market by PET Applications

In the PET applications segment, Oncology maintains the largest market share, with approximately 55% share in 2025, due to its significant role in tumor detection and treatment monitoring. Meanwhile, Neurology stands out as the fastest-growing segment, expected to record a CAGR of 8.7% from 2026 to 2032, driven by increasing incidences of neurological conditions and advancements in imaging technologies.

Global Radiopharmaceuticals & Contrast Media Market by Therapeutic Application

In the therapeutic application segment, Thyroid treatment dominates, accounting for roughly 30% market share in 2025, attributed to its high effectiveness in managing thyroid-related ailments. However, Lymphoma treatment sectors show promising forecasts, with a growth rate of 9.3% CAGR from 2026 to 2032, propelled by rising lymphoma cases and the ongoing research for novel therapeutic radiopharmaceuticals.

Global Radiopharmaceuticals & Contrast Media Market by Contrast Media Type

Among contrast media types, Iodinated Contrast Media continues to lead the market, representing approximately 60% share in 2025 thanks to its extensive use across various imaging modalities. Conversely, Gadolinium-based Contrast Media emerges as the fastest-growing, expected to thrive with a CAGR of 8.2% from 2026 to 2032 owing to its advantages in MRI procedures and patient safety profiles.

Global Radiopharmaceuticals & Contrast Media Market by Procedure

In the procedure segment, X-ray/Computed Tomography (CT) is prominent, commanding around 45% market share in 2025 due to widespread adoption in diagnostic imaging. Alternatively, MRI procedures appear to be experiencing rapid growth, anticipated to achieve a CAGR of 8.8% from 2026 to 2032 as technological advancements improve resolution and patient safety.

Global Radiopharmaceuticals & Contrast Media Market by Application

In application segmentation, Cardiovascular Disease remains the largest area of focus, constituting an estimated 40% share in 2025, primarily due to the rising prevalence of heart conditions and the efficacy of radiopharmaceuticals in diagnostics. Neurological Disorders, in contrast, exhibit the highest growth potential, projected to record a CAGR of 9.1% from 2026 to 2032, influenced by increased diagnostic needs in neurodegenerative diseases.

Global Radiopharmaceuticals & Contrast Media Market by Region

North America remains the largest region in the Global Radiopharmaceuticals & Contrast Media Market, holding an estimated 46% share in 2025. This dominance is reinforced by substantial investments in healthcare infrastructure and a keen focus on early diagnostic procedures. Meanwhile, the Asia-Pacific region is projected to exhibit the highest growth rate, with a CAGR of 8.4% from 2026 to 2032, driven by improving healthcare access, rising disposable incomes, and increasing awareness regarding advanced medical imaging technologies.

Government Initiatives in the Global Radiopharmaceuticals & Contrast Media Market

The regulatory environment surrounding the Global Radiopharmaceuticals & Contrast Media Market is characterized by substantial government support and active initiatives aimed at enhancing the sector's growth. Policies are increasingly focused on facilitating innovation, ensuring patient safety, and promoting the integration of advanced technologies in imaging and therapy.

  • U.S. Food and Drug Administration (FDA) - FDA Guidance for Industry on Expedited Programs for Serious Conditions (2014), aims to accelerate the approval process for radiopharmaceuticals targeting critical health issues.
  • European Medicines Agency (EMA) - Managed access framework (2021), designed to enable early patient access to new medications, including innovative radiopharmaceuticals, through adaptive pathways.
  • Indian Department of Pharmaceuticals - National Policy on Pharmaceuticals (2017), aimed at providing financial incentives for companies innovating in the radiopharmaceuticals sector to bolster domestic production.
  • Health Canada - Health Products and Food Branch (2020), introduced streamlined regulatory processes for radioactive materials involved in medical imaging and therapeutic applications.

Future Insights of the Global Radiopharmaceuticals & Contrast Media Market

By 2032, the Global Radiopharmaceuticals & Contrast Media Market is likely to witness a paradigm shift toward targeted therapies and personalized medicine. R&D initiatives in molecular imaging technologies are pivoting towards integration with genomics, enhancing precision diagnostics. Companies like Siemens Healthineers are already investing in AI-driven analytics to improve imaging interpretation, aligning well with the forecasted trends in patient-centered care and therapeutic monitoring.

Global Radiopharmaceuticals & Contrast Media Market Latest Developments

Recent advancements in the Global Radiopharmaceuticals & Contrast Media Market reflect strategic efforts by leading companies to enhance their market positions and foster innovation.

  • In early 2023, GE Healthcare launched a new multi-modal imaging solution that incorporates radiopharmaceuticals for improved diagnostic clarity, enhancing their competitive edge in oncology.
  • During mid-2023, Bayer AG acquired a small biotechnology firm specializing in PET tracers, positioning itself for future growth in the targeted diagnostics segment.
  • Recently, Cardinal Health expanded its production facility in Ohio to increase output of critical radiopharmaceuticals, addressing the increasing market needs and ensuring higher distribution efficiency.
  • In Q4 2023, Advanced Accelerator Applications initiated clinical trials for a novel radiopharmaceutical aimed at treating specific types of lymphomas, reflecting their commitment to therapeutic innovation.

Global Radiopharmaceuticals & Contrast Media Market Key Players and Industry Positioning

The competitive landscape of the Global Radiopharmaceuticals & Contrast Media Market is characterized by a mix of consolidated and fragmented elements. While leading companies dominate market share, numerous smaller firms are emerging with niche innovations, creating a dynamic yet competitive ecosystem.

Leading Company Core Strength Strategic Focus
GE Healthcare Innovative imaging technology Enhancing oncology diagnostics
Siemens Healthineers Advanced AI integration Improving diagnostic accuracy
Cardinal Health Robust distribution network Increasing production capacity
Bayer AG Rapid product development Targeted therapies for cancer
Advanced Accelerator Applications Specialized in radioisotopes Innovating therapeutic solutions

As the competitive dynamics shift, companies are focusing on collaborations and technological advancements to solidify their presence in targeted markets while meeting changing healthcare demands.

Key Attractiveness of the Report

  • 10 Years of Market Numbers
  • Historical Data Starting from 2022 to 2025
  • Base Year: 2025
  • Forecast Data until 2032
  • Key Performance Indicators Impacting the Market
  • Major Upcoming Developments and Projects

Key Highlights of the Report:

  • Global Radiopharmaceuticals & Contrast Media Market Outlook
  • Market Size of Global Radiopharmaceuticals & Contrast Media Market, 2025
  • Forecast of Global Radiopharmaceuticals & Contrast Media Market, 2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Revenues & Volume for the Period 2022-2032
  • Global Radiopharmaceuticals & Contrast Media Market Trend Evolution
  • Global Radiopharmaceuticals & Contrast Media Market Drivers and Challenges
  • Global Radiopharmaceuticals & Contrast Media Price Trends
  • Global Radiopharmaceuticals & Contrast Media Porter's Five Forces
  • Global Radiopharmaceuticals & Contrast Media Industry Life Cycle
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Type of Imaging Modality for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tc-99 for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tl-201 for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ga-67 for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By I-123 for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECTs for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By F-18 for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Rb-82 for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PETs for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Diagnostic SPECT Application for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiology for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECT Applications for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardology for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Therapeutic Application for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Lymphoma for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Endocrine Tumors for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Therapeutic Applications for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Contrast Media Type for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Iodinated Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gadolinium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Microbubble Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Barium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Procedure for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By X-ray/Computed Tomography (CT) for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Magnetic Resnance Imaging (MRI) for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ultrasound for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Application for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiovascular Disease for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gastrointestinal Disorders for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
  • Historical Data and Forecast of Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Indications for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Type of Imaging Modality for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tc-99 for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tl-201 for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ga-67 for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By I-123 for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECTs for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By F-18 for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Rb-82 for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PETs for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Diagnostic SPECT Application for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiology for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECT Applications for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET Applications for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardology for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PET Applications for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Therapeutic Application for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Lymphoma for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Endocrine Tumors for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Therapeutic Applications for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Contrast Media Type for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Iodinated Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gadolinium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Microbubble Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Barium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Procedure for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By X-ray/Computed Tomography (CT) for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Magnetic Resnance Imaging (MRI) for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ultrasound for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Application for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiovascular Disease for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gastrointestinal Disorders for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
  • Historical Data and Forecast of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Indications for the Period 2022-2032
  • Historical Data and Forecast of United States of America Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Canada Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Rest of North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Type of Imaging Modality for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tc-99 for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tl-201 for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ga-67 for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By I-123 for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECTs for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By F-18 for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Rb-82 for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PETs for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Diagnostic SPECT Application for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiology for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECT Applications for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardology for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Therapeutic Application for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Lymphoma for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Endocrine Tumors for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Therapeutic Applications for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Contrast Media Type for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Iodinated Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gadolinium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Microbubble Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Barium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Procedure for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By X-ray/Computed Tomography (CT) for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Magnetic Resnance Imaging (MRI) for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ultrasound for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Application for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiovascular Disease for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gastrointestinal Disorders for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
  • Historical Data and Forecast of Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Indications for the Period 2022-2032
  • Historical Data and Forecast of Brazil Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Mexico Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Argentina Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Rest of LATAM Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Type of Imaging Modality for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tc-99 for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tl-201 for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ga-67 for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By I-123 for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECTs for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By F-18 for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Rb-82 for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PETs for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Diagnostic SPECT Application for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiology for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECT Applications for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardology for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Therapeutic Application for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Lymphoma for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Endocrine Tumors for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Therapeutic Applications for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Contrast Media Type for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Iodinated Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gadolinium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Microbubble Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Barium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Procedure for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By X-ray/Computed Tomography (CT) for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Magnetic Resnance Imaging (MRI) for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ultrasound for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Application for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiovascular Disease for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gastrointestinal Disorders for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
  • Historical Data and Forecast of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Indications for the Period 2022-2032
  • Historical Data and Forecast of China Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of India Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Japan Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Rest of Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Type of Imaging Modality for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tc-99 for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tl-201 for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ga-67 for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By I-123 for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECTs for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By F-18 for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Rb-82 for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PETs for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Diagnostic SPECT Application for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiology for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECT Applications for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardology for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Therapeutic Application for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Lymphoma for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Endocrine Tumors for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Therapeutic Applications for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Contrast Media Type for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Iodinated Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gadolinium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Microbubble Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Barium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Procedure for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By X-ray/Computed Tomography (CT) for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Magnetic Resnance Imaging (MRI) for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ultrasound for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Application for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiovascular Disease for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gastrointestinal Disorders for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
  • Historical Data and Forecast of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Indications for the Period 2022-2032
  • Historical Data and Forecast of South Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Nigeria Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Egypt Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Rest of Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Type of Imaging Modality for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tc-99 for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tl-201 for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ga-67 for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By I-123 for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECTs for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By F-18 for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Rb-82 for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PETs for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Diagnostic SPECT Application for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiology for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECT Applications for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardology for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Therapeutic Application for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Lymphoma for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Endocrine Tumors for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Therapeutic Applications for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Contrast Media Type for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Iodinated Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gadolinium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Microbubble Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Barium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Procedure for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By X-ray/Computed Tomography (CT) for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Magnetic Resnance Imaging (MRI) for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ultrasound for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Application for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiovascular Disease for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gastrointestinal Disorders for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
  • Historical Data and Forecast of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Indications for the Period 2022-2032
  • Historical Data and Forecast of United Kingdom Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of France Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Germany Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Rest of Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Type of Imaging Modality for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tc-99 for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Tl-201 for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ga-67 for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By I-123 for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECTs for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By F-18 for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Rb-82 for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PETs for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Diagnostic SPECT Application for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiology for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other SPECT Applications for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardology for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurology for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other PET Applications for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Therapeutic Application for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Thyroid for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Lymphoma for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Endocrine Tumors for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Therapeutic Applications for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Contrast Media Type for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Iodinated Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gadolinium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Microbubble Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Barium-based Contrast Media for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Procedure for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By X-ray/Computed Tomography (CT) for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Magnetic Resnance Imaging (MRI) for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Ultrasound for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Application for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Cardiovascular Disease for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Oncology for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Gastrointestinal Disorders for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Neurological Disorders for the Period 2022-2032
  • Historical Data and Forecast of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume By Other Indications for the Period 2022-2032
  • Historical Data and Forecast of Saudi Arabia Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of UAE Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Turkey Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Historical Data and Forecast of Rest of Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume for the Period 2022-2032
  • Global Radiopharmaceuticals & Contrast Media Market - Key Performance Indicators
  • Global Radiopharmaceuticals & Contrast Media Market - Import Export Trade Statistics
  • Global Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment By Countries
  • Global Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment By Type of Imaging Modality
  • Global Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment By PET
  • Global Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment By Diagnostic SPECT Application
  • Global Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment By PET Applications
  • Global Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment By Therapeutic Application
  • Market Opportunity Assessment By Contrast Media Type
  • Market Opportunity Assessment By Procedure
  • Market Opportunity Assessment By Application
  • Global Radiopharmaceuticals & Contrast Media Market - Top Companies Market Share
  • Global Radiopharmaceuticals & Contrast Media Market - Top Companies Profiles
  • Global Radiopharmaceuticals & Contrast Media Market - Comparison of Players in Technical and Operating Parameters
  • Global Radiopharmaceuticals & Contrast Media Market - Strategic Recommendations

Markets Covered

The Global Radiopharmaceuticals & Contrast Media Market report provides a detailed analysis of the following market segments:

By Regions and Countries:

  • North America
  • Europe
  • LATAM
  • Middle East
  • Asia
  • Africa

By Type of Imaging Modality:

  • Tc-99
  • Tl-201
  • Ga-67
  • I-123
  • Other SPECTs

By PET:

  • F-18
  • Rb-82
  • Other PETs

By Diagnostic SPECT Application:

  • Cardiology
  • Neurology
  • Thyroid
  • Other SPECT Applications

By PET Applications:

  • Oncology
  • Cardology
  • Neurology
  • Other PET Applications

By Therapeutic Application:

  • Thyroid
  • Lymphoma
  • Endocrine Tumors
  • Other Therapeutic Applications

By Contrast Media Type:

  • Iodinated Contrast Media
  • Gadolinium-based Contrast Media
  • Microbubble Contrast Media
  • Barium-based Contrast Media

By Procedure:

  • X-ray/Computed Tomography (CT)
  • Magnetic Resnance Imaging (MRI)
  • Ultrasound

By Application:

  • Cardiovascular Disease
  • Oncology
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Other Indications

Global Radiopharmaceuticals & Contrast Media Market - Frequently Asked Questions

What is the projected market size of the Global Radiopharmaceuticals & Contrast Media Market by 2032?
The Global Radiopharmaceuticals & Contrast Media Market is projected to reach USD 22.2 Billion by 2032.
What is the expected growth rate of the Global Radiopharmaceuticals & Contrast Media Market from 2026 to 2032?
The market is estimated to grow at a CAGR of 7.13% from 2026 to 2032.
What are the primary drivers of growth in this market?
Key drivers include advancements in imaging technologies and the rising prevalence of cancer, prompting increased use of radiopharmaceuticals.
What are the main challenges faced by the industry?
Challenges include stringent regulatory approvals and high development costs, which may hinder market entry for new innovations.
Which segments are expected to lead in the market?
Tc-99 is anticipated to maintain its dominance, while Other SPECTs will show the highest growth rate during the forecast period.
What does the future outlook for the Global Radiopharmaceuticals & Contrast Media Market indicate?
Future insights point towards increased integration of AI in diagnostics and a shift towards personalized medicine, further enhancing patient care.
How does 6Wresearch market report help businesses in making strategic decisions?
6Wresearch actively monitors the Global Radiopharmaceuticals & Contrast Media Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Global Radiopharmaceuticals & Contrast Media Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Global Radiopharmaceuticals & Contrast Media Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Global Radiopharmaceuticals & Contrast Media Market Overview

3.1 Global Regional Macro Economic Indicators

3.2 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2022 & 2032F

3.3 Global Radiopharmaceuticals & Contrast Media Market - Industry Life Cycle

3.4 Global Radiopharmaceuticals & Contrast Media Market - Porter's Five Forces

3.5 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Regions, 2022 & 2032F

3.6 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Type of Imaging Modality, 2022 & 2032F

3.7 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET, 2022 & 2032F

3.8 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Diagnostic SPECT Application, 2022 & 2032F

3.9 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By PET Applications, 2022 & 2032F

3.10 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Therapeutic Application, 2022 & 2032F

3.11 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Contrast Media Type, 2022 & 2032F

3.12 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Procedure, 2022 & 2032F

3.13 Global Radiopharmaceuticals & Contrast Media Market Revenues & Volume Share, By Application, 2022 & 2032F

4 Global Radiopharmaceuticals & Contrast Media Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Global Radiopharmaceuticals & Contrast Media Market Trends

6 Global Radiopharmaceuticals & Contrast Media Market, 2022-2032

6.1 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2022-2032

6.1.1 Overview & Analysis

6.1.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tc-99, 2022-2032

6.1.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Tl-201, 2022-2032

6.1.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ga-67, 2022-2032

6.1.5 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By I-123, 2022-2032

6.1.6 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECTs, 2022-2032

6.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2022-2032

6.2.1 Overview & Analysis

6.2.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By F-18, 2022-2032

6.2.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Rb-82, 2022-2032

6.2.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PETs, 2022-2032

6.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2022-2032

6.3.1 Overview & Analysis

6.3.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiology, 2022-2032

6.3.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2022-2032

6.3.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2022-2032

6.3.5 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other SPECT Applications, 2022-2032

6.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2022-2032

6.4.1 Overview & Analysis

6.4.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2022-2032

6.4.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardology, 2022-2032

6.4.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurology, 2022-2032

6.4.5 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other PET Applications, 2022-2032

6.5 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2022-2032

6.5.1 Overview & Analysis

6.5.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Thyroid, 2022-2032

6.5.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Lymphoma, 2022-2032

6.5.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Endocrine Tumors, 2022-2032

6.5.5 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Therapeutic Applications, 2022-2032

6.6 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2022-2032

6.6.1 Overview & Analysis

6.6.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Iodinated Contrast Media, 2022-2032

6.6.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gadolinium-based Contrast Media, 2022-2032

6.6.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Microbubble Contrast Media, 2022-2032

6.6.5 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Barium-based Contrast Media, 2022-2032

6.7 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2022-2032

6.7.1 Overview & Analysis

6.7.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By X-ray/Computed Tomography (CT), 2022-2032

6.7.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Magnetic Resnance Imaging (MRI), 2022-2032

6.7.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Ultrasound, 2022-2032

6.8 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2022-2032

6.8.1 Overview & Analysis

6.8.2 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Cardiovascular Disease, 2022-2032

6.8.3 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Oncology, 2022-2032

6.8.4 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Gastrointestinal Disorders, 2022-2032

6.8.5 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Neurological Disorders, 2022-2032

6.8.6 Global Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Other Indications, 2022-2032

7 North America Radiopharmaceuticals & Contrast Media Market, Overview & Analysis

7.1 North America Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2022-2032

7.2 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Countries, 2022-2032

7.2.1 United States (US) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

7.2.2 Canada Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

7.2.3 Rest of North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

7.3 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2022-2032

7.4 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2022-2032

7.5 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2022-2032

7.6 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2022-2032

7.7 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2022-2032

7.8 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2022-2032

7.9 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2022-2032

7.10 North America Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2022-2032

8 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Overview & Analysis

8.1 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2022-2032

8.2 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Countries, 2022-2032

8.2.1 Brazil Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

8.2.2 Mexico Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

8.2.3 Argentina Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

8.2.4 Rest of LATAM Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

8.3 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2022-2032

8.4 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2022-2032

8.5 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2022-2032

8.6 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2022-2032

8.7 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2022-2032

8.8 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2022-2032

8.9 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2022-2032

8.10 Latin America (LATAM) Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2022-2032

9 Asia Radiopharmaceuticals & Contrast Media Market, Overview & Analysis

9.1 Asia Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2022-2032

9.2 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Countries, 2022-2032

9.2.1 India Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

9.2.2 China Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

9.2.3 Japan Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

9.2.4 Rest of Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

9.3 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2022-2032

9.4 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2022-2032

9.5 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2022-2032

9.6 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2022-2032

9.7 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2022-2032

9.8 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2022-2032

9.9 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2022-2032

9.10 Asia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2022-2032

10 Africa Radiopharmaceuticals & Contrast Media Market, Overview & Analysis

10.1 Africa Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2022-2032

10.2 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Countries, 2022-2032

10.2.1 South Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

10.2.2 Egypt Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

10.2.3 Nigeria Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

10.2.4 Rest of Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

10.3 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2022-2032

10.4 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2022-2032

10.5 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2022-2032

10.6 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2022-2032

10.7 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2022-2032

10.8 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2022-2032

10.9 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2022-2032

10.10 Africa Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2022-2032

11 Europe Radiopharmaceuticals & Contrast Media Market, Overview & Analysis

11.1 Europe Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2022-2032

11.2 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Countries, 2022-2032

11.2.1 United Kingdom Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

11.2.2 Germany Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

11.2.3 France Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

11.2.4 Rest of Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

11.3 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2022-2032

11.4 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2022-2032

11.5 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2022-2032

11.6 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2022-2032

11.7 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2022-2032

11.8 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2022-2032

11.9 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2022-2032

11.10 Europe Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2022-2032

12 Middle East Radiopharmaceuticals & Contrast Media Market, Overview & Analysis

12.1 Middle East Radiopharmaceuticals & Contrast Media Market Revenues & Volume, 2022-2032

12.2 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Countries, 2022-2032

12.2.1 Saudi Arabia Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

12.2.2 UAE Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

12.2.3 Turkey Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, 2022-2032

12.3 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Type of Imaging Modality, 2022-2032

12.4 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET, 2022-2032

12.5 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Diagnostic SPECT Application, 2022-2032

12.6 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By PET Applications, 2022-2032

12.7 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Therapeutic Application, 2022-2032

12.8 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Contrast Media Type, 2022-2032

12.9 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Procedure, 2022-2032

12.10 Middle East Radiopharmaceuticals & Contrast Media Market, Revenues & Volume, By Application, 2022-2032

13 Global Radiopharmaceuticals & Contrast Media Market Key Performance Indicators

14 Global Radiopharmaceuticals & Contrast Media Market - Export/Import By Countries Assessment

15 Global Radiopharmaceuticals & Contrast Media Market - Opportunity Assessment

15.1 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Countries, 2022 & 2032F

15.2 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Type of Imaging Modality, 2022 & 2032F

15.3 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET, 2022 & 2032F

15.4 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Diagnostic SPECT Application, 2022 & 2032F

15.5 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By PET Applications, 2022 & 2032F

15.6 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Therapeutic Application, 2022 & 2032F

15.7 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Contrast Media Type, 2022 & 2032F

15.8 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Procedure, 2022 & 2032F

15.9 Global Radiopharmaceuticals & Contrast Media Market Opportunity Assessment, By Application, 2022 & 2032F

16 Global Radiopharmaceuticals & Contrast Media Market - Competitive Landscape

16.1 Global Radiopharmaceuticals & Contrast Media Market Revenue Share, By Companies, 2025

16.2 Global Radiopharmaceuticals & Contrast Media Market Competitive Benchmarking, By Operating and Technical Parameters

17 Top 10 Company Profiles

18 Recommendations

19 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here

Related Report Available


×
Go to New Report No! I want to read this
Request Primary Research & Report
  • Single User License
    $4,560
  • Department License
    $5,055
  • Site License
    $5,595
  • Global License
    $6,000
Order Now
ISO 9001:2015

ISO 9001:2015 CERTIFIED

Quality Management System for market research & advisory services

Cert. No. 3050261008135Q

PDF ↓ Verify Certificate ↗
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Search

6Wresearch in the News

Forbes

Citing 6Wresearch analytics to map global infrastructure and pharmaceutical industry trajectories.

Read coverage →
Bloomberg Law

Direct syndication of 6Wresearch's macro data points, capturing complex supply chain shifts.

Read coverage →
Reuters

Tracking industrial manufacturing adjustments and electronic security ecosystem scaling.

Read coverage →
Mint

Utilizing deep-tech sector market sizing to analyze global automation and robotics.

Read coverage →
The Economic Times

Anchoring features on industrial IoT growth metrics and connected smart-grid devices.

Read coverage →
Business Standard

Featuring strategic evaluations of Advanced Driver Assistance Systems (ADAS) and AI road safety.

Read coverage →
The Hindu

Spotlighting core commercial metrics ranging from unmanned aerial vehicles (UAVs) to consumer durables.

Read coverage →
Financial Express

Anchoring quarterly reviews on cross-border real estate tech and structural hardware manufacturing.

Read coverage →
Yahoo Finance

Syndicating the tracker's $30.1 billion untapped-market findings, spotlighting Japan, the US and China as India's top new-potential importers.

Read coverage →
India Today

Carrying the release on smartphones leading India's export potential to $94 billion by 2031, per 6WExportGTM data.

Read coverage →
Dailyhunt

Distributing the tracker findings to its regional readership, framing India's export diversification into Japan and Mexico.

Read coverage →
PR Newswire Original release

Publishing the full India Export Attractiveness Tracker 2026, detailing new trade corridors across iron ore, LCVs and pharmaceuticals.

Read coverage →
The Industrial

Highlighting the tracker's read on India's semiconductor ambitions and long-term chip-assembly export potential.

Read coverage →
PTI News

Reporting on the $66.81 billion pharmaceuticals export opportunity flagged in the tracker, amid looming US generic-drug tariffs.

Read coverage →
Tribune India

Covering the tracker's tariff-versus-regulation analysis across India's mature export markets in the US, China and UAE.

Read coverage →
ANI News

Amplifying the report's findings on polished diamonds, refined petroleum and medicines as India's core export engines.

Read coverage →
International Business Magazine

Covering the report's insight into how AEB, blind spot detection, and driver monitoring are reshaping India's ADAS market.

Read coverage →
Focus Gaming News

Highlighting the research forecast for Egypt's gambling market, projecting steady growth through 2032.

Read coverage →

Thought Leadership and Analyst Meet

Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
View All

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

View All

Industry Events and Analyst Meet

Energy Digitalisation & AI Summit (EDAS 2026)

Energy Digitalisation & AI Summit (EDAS 2026)

12th IVASS 2026

12th IVASS 2026

EV India Expo 2026

EV India Expo 2026

HIMTEX 2026

HIMTEX 2026

India Refining Summit 2026

India Refining Summit 2026

Whitepaper

Read All

WHERE WE WORK

Our Global Presence

Headquartered in New Delhi, with offices and country partners across key markets worldwide, so every engagement draws on local market insight.

India

Head Office

6Wresearch Head Office

Global Headquarters, New Delhi

3rd Floor, Pearls Omaxe Tower, 4-5-6, Netaji Subhash Place, Pitampura, New Delhi, Delhi 110034
sales@6wresearch.com(+91) 11-4302-4305

Japan

Country Partner

Shuhei Umetani

Consultant and Business Owner

4, Sakaemachidori, Chuo-ku, Kobe, Hyogo, Japan

South Korea

Country Partner

Seung-ho Oh

Vice President · 6Wresearch Country Consultant – South Korea

2F, 41 World Cup buk-ro 5-gil, Mapo-gu, Seoul, Korea

China

Country Partner

Dayong Cheng

Independent Consultant / Field Researcher

Juye County, Heze City, Shandong Province, China

Thailand

Country Office

Cyrus Reid

6Wresearch Country Research Representative – Thailand

64/25 Venue Rama 5-3, Nakorn-in Road, Bangphai, Mueang, Nonthaburi (Thailand) 11000

Vietnam

Country Office

Nguyen Quoc Hung

6Wresearch Country Research Representative – Vietnam

7th Flr. Loc Le Building, 454 Nguyen Thi Minh Khai Street, Ban Co Ward, Ho Chi Minh City, Vietnam
About Us

6Wresearch, branded as 6W, is a commercial strategy and growth advisory firm founded in 2011 and headquartered in New Delhi, India, with partners across Southeast Asia and the Middle East & Africa. The firm has delivered more than 20,000 commercial engagements for over 2,000 organizations, including Fortune 500 companies, government agencies, and multilateral institutions such as the World Bank and Asian Development Bank. 6Wresearch combines proprietary intelligence, advanced analytics, and sector expertise to help organizations navigate market complexity and drive sustainable growth.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Market Takeaways
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
6Wresearch FAQs
Disclaimer
Contact Us
Thought Leadership and Analyst Meet
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
Agriculture
ISO 9001

ISO 9001:2015 Certified Company

6Wresearch operates an ISO 9001:2015 certified Quality Management System
for market research & advisory services. Cert. No. 3050261008135Q

↓ Download Certificate Verify Certificate ↗
©2026 6Wresearch, All Right Reserved